CALC - CIK 0001534133
The table below shows CalciMedica, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$21.18M | -$21.15M | -$25.73M | -$11.76M | -$31.50M | -$32.06M |
| Capital expenditure | $28.00K | $8.00K | $78.00K | $4.00K | $488.00K | $1.02M |
| Investing cash flow | $9.55M | -$4.42M | $8.88M | -$4.00K | $10.75M | -$42.56M |
| Dividends paid | - | - | - | - | - |
CalciMedica, Inc. reported operating cash flow of -$21.18M for fiscal year 2025. That is down 0.2% from -$21.15M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$31.21M (FY 2019) to -$21.18M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $15.21M | $27.97M | $20.90M | $8.48M | $695.00K | $92.17M |